These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19124397)

  • 21. The role of the renin-angiotensin system in the pathophysiology, prevention, and treatment of renal impairment in patients with the cardiometabolic syndrome or its components.
    Alpert MA; Govindarajan G; Del Rosario ML; Reisin E
    J Cardiometab Syndr; 2009; 4(1):57-62. PubMed ID: 19245518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dysmetabolic symptomatic arterial hypertension and dysmetabolic disease].
    Bokarev IN; Shubina OI
    Klin Med (Mosk); 2009; 87(8):67-71. PubMed ID: 19827536
    [No Abstract]   [Full Text] [Related]  

  • 23. The metabolic syndrome and the risk of arterial and venous thrombosis.
    Franchini M; Targher G; Montagnana M; Lippi G
    Thromb Res; 2008; 122(6):727-35. PubMed ID: 17996282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The burden of stroke in Nigeria.
    Wahab KW
    Int J Stroke; 2008 Nov; 3(4):290-2. PubMed ID: 18811746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of the metabolic syndrome and its influencing factors among adolescent girls in Mashhad, Iran.
    Mirhosseini NZ; Yusoff NA; Shahar S; Parizadeh SM; Mobarhen MG; Shakery MT
    Asia Pac J Clin Nutr; 2009; 18(1):131-6. PubMed ID: 19329406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A province-based surveillance system for the risk factors of non-communicable diseases: A prototype for integration of risk factor surveillance into primary healthcare systems of developing countries.
    Alikhani S; Delavari A; Alaedini F; Kelishadi R; Rohbani S; Safaei A
    Public Health; 2009 May; 123(5):358-64. PubMed ID: 19386334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between physical activity and metabolic syndrome in Iranian adults: national surveillance of risk factors of noncommunicable diseases (SuRFNCD-2007).
    Esteghamati A; Khalilzadeh O; Rashidi A; Meysamie A; Haghazali M; Abbasi M; Asgari F; Gouya MM
    Metabolism; 2009 Sep; 58(9):1347-55. PubMed ID: 19501857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of hypertension in the cardiometabolic syndrome.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
    J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
    J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The message for World Kidney Day 2009: hypertension and kidney disease--a marriage that should be prevented.
    Bakris GL; Ritz E;
    J Hum Hypertens; 2009 Mar; 23(3):222-5. PubMed ID: 19158823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metabolic syndrome and chronic disease of the kidneys: the role of age-related androgenic deficiency. New approaches to treatment (review)].
    Novikova MS; Kalinchenko SIu; Borisov VV
    Ter Arkh; 2008; 80(10):41-6. PubMed ID: 19105413
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiovascular disease risk factors, metabolic syndrome and obesity in an Iranian population.
    Kelishadi R; Gharipour M; Sadri GH; Tavasoli AA; Amani A
    East Mediterr Health J; 2008; 14(5):1070-9. PubMed ID: 19161079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High blood pressure in Latin America: a call to action.
    Rubinstein A; Alcocer L; Chagas A
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):259-85. PubMed ID: 19561117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic Syndrome: Bridging the Gap from Childhood to Adulthood.
    Agirbasli M; Tanrikulu AM; Berenson GS
    Cardiovasc Ther; 2016 Feb; 34(1):30-6. PubMed ID: 26588351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D metabolism and cardiovascular risk factors in postmenopausal women.
    Pérez-López FR
    Maturitas; 2009 Mar; 62(3):248-62. PubMed ID: 19211206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Worldwide use of intrauterine devices for contraception.
    d'Arcangues C
    Contraception; 2007 Jun; 75(6 Suppl):S2-7. PubMed ID: 17531612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic syndrome in pediatrics: old concepts revised, new concepts discussed.
    D'Adamo E; Santoro N; Caprio S
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):549-63. PubMed ID: 19717004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.
    Collins AJ; Vassalotti JA; Wang C; Li S; Gilbertson DT; Liu J; Foley RN; Chen SC; Arneson TJ
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S71-7. PubMed ID: 19231764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome in Africa: an emerging perspective.
    Onyegbutulem HC; H-Onyegbutulem PI; Reimann M; Li J; Bornstein SR; Schwarz PE
    Horm Metab Res; 2009 Feb; 41(2):75-8. PubMed ID: 19085825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.